1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Topics

Showing 234 results for "Multiple Myeloma (MM)".

Thumbnail for The Age-Race Paradox in Multiple Myeloma: Younger Diagnosis but Persistent Early Mortality Among Black Patients in the United States

MM - 1606

The Age-Race Paradox in Multiple Myeloma: Younger Diagnosis but Persistent Early Mortality Among Black Patients in the United States

Sai Lahari Sangaraju

Poster Presenter: Sai Lahari Sangaraju

MM - 162

Bilateral Central Retinal Vein Occlusion in Plasma Cell Dyscrasias: Implications for Hyperviscosity in Multiple Myeloma

Zhengxuan Li

Poster Presenter: Zhengxuan Li

$Thumbnail for Belantamab Mafodotin Combinations in Relapsed or Refractory Multiple Myeloma: Re-emergence of BCMA Antibody-Drug Conjugate Therapy Across Clinical Trials$

SOHO 2026 Annual Meeting

Topics

The Age-Race Paradox in Multiple Myeloma: Younger Diagnosis but Persistent Early Mortality Among Black Patients in the United States

Bilateral Central Retinal Vein Occlusion in Plasma Cell Dyscrasias: Implications for Hyperviscosity in Multiple Myeloma

Belantamab Mafodotin Combinations in Relapsed or Refractory Multiple Myeloma: Re-emergence of BCMA Antibody-Drug Conjugate Therapy Across Clinical Trials

Multiple Myeloma and Chronic Kidney Disease-Related Mortality, 1999-2023: A Population-Based Time-Trend Analysis

Environmental Double Burden in Multiple Myeloma: PM2.5 Exposure and Racial Outcome Disparities Among Non-Hispanic Black and White Patients in the United States

Impact of Diabetes Mellitus on Outcomes in Multiple Myeloma Patients Receiving Bispecific Antibodies: A Real-World Analysis

When Is Stopping Safe? Fixed-Duration Therapy and Treatment-Free Remission in Hematologic Malignancies: A Scoping Review

Beyond a benign label: Mortality Trends Associated with Monoclonal Gammopathy of Undetermined Significance Among Adults Aged =45 Years in the United States, 1999-2024

Prophylactic Tocilizumab During Bispecific Antibody Step-Up Dosing in Relapsed/Refractory Multiple Myeloma: CRS Mitigation, Low-Dose Strategies, and Outpatient Feasibility